Recent

% | $
Quotes you view appear here for quick access.

ANI Pharmaceuticals, Inc. Message Board

you are viewing a single comment's thread.

view the rest of the posts
  • sanantonlinda sanantonlinda Jun 10, 2011 12:22 PM Flag

    Analysis of CFO Phil Donenberg's response.

    Perhaps BPAX realizes that they are only grooming Libigel's results for buyout. This could happen this fall. Suitors are not as picky as FDA and can extrapolate results from the initial enrollees. I have never thought that BPAX would produce and market Libigel.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • That's absoultely right. But if that's the case then who really cares what they do or say in the presentation? Follow the SPA, as it's dictated.

      I'm not sure that's the reason. It may be, but it really wouldn't make any sense. It's a deviation from the SPA which they do not need to make.

      One thing is for sure, something has changed. Hopefully it is good for the shareholders.

 
ANIP
66.64-0.17(-0.25%)Sep 23 4:00 PMEDT